The following financial results are for the three months ended June 30, 2017, compared to the three months ended June 30, 2016:
- Revenue was $1.5 million compared to $4.2 million one year ago.
- Operating loss was $5.5 million, compared to a loss of $3.5 million for the same quarter one year ago.
- Net loss was $5.5 million, or $0.08 per share, compared to a loss of $3.5 million, or $0.07 per share for the same quarter one year ago.
- In the second quarter 2017 cash provided by operations was $4.6 million compared to cash used in operations of $4.1 million for the same period in 2016. Cash provided by operations in the quarter includes the $10 million upfront payment and $4 million in payments under the April 2017 development contract.
Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision's IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Wash.For more information, visit the company's website at www.microvision.com, on Facebook at www.facebook.com/MicroVisionInc or follow MicroVision on Twitter at @MicroVision. MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners. Forward-Looking Statements Certain statements contained in this release, including those relating to future payments, performance and timing of development work under development agreements, shipment of products pursuant to purchase orders, availability of future products and product applications, and those containing words such as "expects" or "scheduled" are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP display engine may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
|June 30,||December 31,|
|Cash and cash equivalents||$||17,744||$||15,139|
|Accounts receivable, net||805||245|
|Other current assets||4,233||731|
|Total current assets||25,459||17,348|
|Property and equipment, net||3,299||1,537|
|Intangible assets, net||660||718|
|Liabilities and Shareholders' Equity|
|Billings on uncompleted contracts in excess of related costs||3,667||168|
|Other current liabilities||10,070||178|
|Total current liabilities||21,294||7,244|
|Deferred revenue, net of current portion||4,654||5,150|
|Deferred rent, net of current portion||102||185|
|Other long-term liabilities||36||53|
|Commitments and contingencies|
|Common stock at par value||72||68|
|Additional paid-in capital||514,737||507,249|
|Total shareholders' equity||3,825||7,474|
|Total liabilities and shareholders' equity||$||29,911||$||20,106|
|Statement of Operations|
|(In thousands, except earnings per share data)|
|Three months ended June 30,||Six months ended June 30,|
|Cost of product revenue||135||2,587||348||5,175|
|Cost of contract revenue||810||5||1,135||6|
|Total cost of revenue||945||2,592||1,483||5,181|
|Research and development expense||3,672||2,879||6,990||5,476|
|Sales, marketing, general and administrative expense||2,325||2,171||4,905||4,239|
|Total operating expenses||5,997||5,050||11,895||9,715|
|Loss from operations||(5,489||)||(3,487||)||(11,133||)||(7,040||)|
|Other expenses, net||(5||)||11||(8||)||8|
|Net loss per share - basic and diluted||$||(0.08||)||$||(0.07||)||$||(0.16||)||$||(0.14||)|
|Weighted-average shares outstanding - basic and diluted||69,373||51,567||68,747||49,566|